News

Officials in sixteen states and the District of Columbia sued in response, leading to Tuesday’s order from U.S. District ...
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.
Biotech and pharmaceutical stocks were sliding Tuesday afternoon as the Food and Drug Administration named Dr. Vinay Prasad, ...
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
(CTN News) – The Food and Drug Administration (FDA) has elected to appoint a new director for the Center for Biologics ...
The French pharma group has just been granted a fast-track designation from the FDA for a preclinical-stage mRNA-based vaccine candidate that is due to start a phase 1/2 trial in the coming days ...